Platinum based theranostics nanoplatforms for antitumor applications
Platinum (Pt) based nanoplatforms are biocompatible nanoagents with photothermal antitumor performance, while exhibiting excellent radiotherapy sensitization properties. Pt-nanoplatforms have extensive research prospects in the realm of cancer treatment due to their highly selective and minimally invasive treatment mode with low damage, and integrated diagnosis and treatment with image monitoring and collaborative drug delivery. Platinum based anticancer chemotherapeutic drugs can kill tumor cells by damaging DNA through chemotherapy. Meanwhile, Pt-nanoplatforms also have good electrocatalytic activity, which can mediate novel electrodynamic therapy. Simultaneously, Pt(II) based compounds also have potential as photosensitizers in photodynamic therapy for malignant tumors. Pt-nanoplatforms can also modulate the immunosuppressive environment and synergistically ablate tumor cells in combination with immune checkpoint inhibitors. This article reviews the research progress of platinum based nanoplatforms in new technologies for cancer therapy, starting from widely representative examples of platinum based nanoplatforms in chemotherapy, electrodynamic therapy, photodynamic therapy, photothermal therapy, and immunotherapy. Finally, multimodal imaging techniques of platinum based nanoplatforms for biomedical diagnosis are briefly discussed.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
---|---|
Enthalten in: |
Journal of materials chemistry. B - 11(2023), 35 vom: 13. Sept., Seite 8387-8403 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Li, Heying [VerfasserIn] |
---|
Links: |
---|
Themen: |
49DFR088MY |
---|
Anmerkungen: |
Date Completed 14.09.2023 Date Revised 14.09.2023 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1039/d3tb01035j |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM360805787 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM360805787 | ||
003 | DE-627 | ||
005 | 20231226083811.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1039/d3tb01035j |2 doi | |
028 | 5 | 2 | |a pubmed24n1202.xml |
035 | |a (DE-627)NLM360805787 | ||
035 | |a (NLM)37581251 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Li, Heying |e verfasserin |4 aut | |
245 | 1 | 0 | |a Platinum based theranostics nanoplatforms for antitumor applications |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 14.09.2023 | ||
500 | |a Date Revised 14.09.2023 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Platinum (Pt) based nanoplatforms are biocompatible nanoagents with photothermal antitumor performance, while exhibiting excellent radiotherapy sensitization properties. Pt-nanoplatforms have extensive research prospects in the realm of cancer treatment due to their highly selective and minimally invasive treatment mode with low damage, and integrated diagnosis and treatment with image monitoring and collaborative drug delivery. Platinum based anticancer chemotherapeutic drugs can kill tumor cells by damaging DNA through chemotherapy. Meanwhile, Pt-nanoplatforms also have good electrocatalytic activity, which can mediate novel electrodynamic therapy. Simultaneously, Pt(II) based compounds also have potential as photosensitizers in photodynamic therapy for malignant tumors. Pt-nanoplatforms can also modulate the immunosuppressive environment and synergistically ablate tumor cells in combination with immune checkpoint inhibitors. This article reviews the research progress of platinum based nanoplatforms in new technologies for cancer therapy, starting from widely representative examples of platinum based nanoplatforms in chemotherapy, electrodynamic therapy, photodynamic therapy, photothermal therapy, and immunotherapy. Finally, multimodal imaging techniques of platinum based nanoplatforms for biomedical diagnosis are briefly discussed | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a Platinum |2 NLM | |
650 | 7 | |a 49DFR088MY |2 NLM | |
650 | 7 | |a Antineoplastic Agents |2 NLM | |
700 | 1 | |a Cheng, Shaowen |e verfasserin |4 aut | |
700 | 1 | |a Zhai, Jingming |e verfasserin |4 aut | |
700 | 1 | |a Lei, Kun |e verfasserin |4 aut | |
700 | 1 | |a Zhou, Ping |e verfasserin |4 aut | |
700 | 1 | |a Cai, Kaiyong |e verfasserin |4 aut | |
700 | 1 | |a Li, Jinghua |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of materials chemistry. B |d 2013 |g 11(2023), 35 vom: 13. Sept., Seite 8387-8403 |w (DE-627)NLM225907968 |x 2050-7518 |7 nnns |
773 | 1 | 8 | |g volume:11 |g year:2023 |g number:35 |g day:13 |g month:09 |g pages:8387-8403 |
856 | 4 | 0 | |u http://dx.doi.org/10.1039/d3tb01035j |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 11 |j 2023 |e 35 |b 13 |c 09 |h 8387-8403 |